People · Operator
Named in public records as an officer, director or promoter · active 2015–2018 · Biotechnology, Manufacturing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Delphinus Medical Technologies, Inc. | — | Biotechnology | Series B | $117.9M | $221.7M | 2015 |
| Neochord Inc | — | Manufacturing | Series B | $78.2M | $2.4M | 2017 |
Michael J. Fulton at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael J. Fulton on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Gross | 1 | 9 |
| Scott White | 1 | 7 |
| David Neustaedter | 1 | 7 |
| Paul McCreadie | 1 | 6 |
| Steven J. Healy | 1 | 5 |
| John Seaberg | 1 | 5 |
| Timothy I Maudlin | 1 | 4 |
| Mudit K. Jain | 1 | 4 |
| John Neis | 1 | 3 |
| Todd Berg | 1 | 3 |
| Casey K. Tansey | 1 | 3 |
| Nicole J. Walker | 1 | 3 |
| Kyle Salyers | 1 | 2 |
| Casey J. Tansey | 1 | 2 |
| Michael Fulton | 1 | 2 |
| Rachel Brem | 1 | 2 |
| Greg Maurer | 1 | 2 |
| Michael J. Gross | 1 | 2 |
| John Zentgraf | 1 | 2 |
| Mark J. Forchette | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.